CalciMedica, Inc.
For the period ended Sep 30, 2025. Filed Nov 12, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 12, 2025
CALC$1.52+11.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| ExhibitNumber · Description · Form · File No. · ExhibitFiling Date · ExhibitNo. · Filed/FurnishedHerewith | |||||
|---|---|---|---|---|---|
| 3.1 | Amended and Restated Certificate of Incorporation of the Registrant. | 8-K | 001-39538 | March 22, 2023 | 3.1 |
| 3.2 | Certificate of Amendment, dated March 20, 2023 to Amended and Restated Certificate of Incorporation of the Registrant. | 8-K | 001-39538 | March 22, 2023 | 3.2 |
| 3.3 | Restated Bylaws of the Registrant. | 10-Q | 001-39538 | November 12, 2020 | 3.2 |
| 4.1 | Reference is made to Exhibits 3.1, 3.2 and 3.3. | ||||
| 4.2 | Form of Common Stock Certificate | S-1/A | 333-248611 | September 21, 2020 | 4.1 |
| 4.3 | Form of Registration Rights Agreement, dated November 21, 2022, by and among CalciMedica, Inc. and the several purchasers signatory thereto. | 8-K | 001-39538 | March 22, 2023 | 4.1 |
| 4.4 | Form of Registration Rights Agreement by and among CalciMedica, Inc. and the persons party thereto. | 8-K | 001-39538 | January 24, 2024 | 10.2 |
| 4.5 | Warrant to Purchase Common Stock dated as of December 11, 2019, by and between the Registrant and SG Dan Equity Holdings, LLC. | S-1 | 333-248611 | September 4, 2020 | 4.3 |
| 4.6 | Form of Warrant to Purchase Shares of Series D Convertible Preferred Stock of CalciMedica, Inc. | 8-K | 001-39538 | March 22, 2023 | 4.2 |
| 4.7 | Warrant to Purchase Common Stock dated as of November 9, 2020, issued by the Registrant to SG Dan Equity Holdings, LLC. | 8-K | 001-39538 | March 22, 2023 | 4.3 |
| 4.8 | Warrant to Purchase Common Stock, dated as of October 18, 2022, issued by CalciMedica, Inc. to SG Dan Equity Holdings, LLC. | 8-K | 001-39538 | March 22, 2023 | 4.4 |
| 4.9 | Warrant to Purchase Common Stock, dated as of October 18, 2022, issued by CalciMedica, Inc. to Eric Roberts. | 8-K | 001-39538 | March 22, 2023 | 4.5 |
| 4.10 | Warrant to Purchase Common Stock, dated as of October 25,2022, issued by CalciMedica, Inc. to Fred Middleton. | 8-K | 001-39538 | March 22, 2023 | 4.6 |
| 4.11 | Form of Warrant to Purchase Shares of Series B Convertible Preferred Stock of CalciMedica, Inc. | S-3 | 333-271115 | April 4, 2023 | 4.9 |
| 4.12 | Form of Tranche B Common Warrant | 8-K | 001-39538 | January 24, 2024 | 4.2 |
| 4.13 | Form of Pre-Funded Warrant | 8-K | 001-39538 | January 24, 2024 | 4.3 |
| ExhibitNumber | Description | Form | File No. | ExhibitFiling Date | ExhibitNo. | Filed/FurnishedHerewith |
|---|---|---|---|---|---|---|
| 4.14 | Form of Placement Agent Warrant | 8-K | 001-39538 | January 24, 2024 | 4.4 | |
| 4.15 | Warrant to Purchase Common Stock, dated as of May 17, 2024, issued by the Registrant to SG Dan Equity Holdings, LLC. | 10-Q | 001-39538 | August 12, 2024 | 4.16 | |
| 4.16 | Warrant to Purchase Shares of Stock of CalciMedica, Inc. dated February 28, 2025, by and between CalciMedica, Inc. and Avenue Venture Opportunities Fund II, LP. | 8-K | 001-39538 | March 5, 2025 | 4.1 | |
| 31.1 | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 31.2 | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.1* | Certification of Principal Executive Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 32.2* | Certification of Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 101.INS | Inline XBRL Instance Document. | X | ||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents. | X | ||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | X | ||||
- This certification is deemed not filed for purposes of section 18 of the Exchange Act or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of the Exchange Act.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.